Average UK house asking price sees steepest monthly drop in 20 years
Property portal Rightmove reported that the average asking price now stands at £373,709, marking a 1.2 per cent or £4,531 decrease month-on-month.
While a seasonal dip in prices is typical for July, this years' drop is the most significant recorded by Rightmove for this time of year across its more than 20 years of data.
Rightmove has also cut its house price forecast for 2025 from 4 per cent growth to 2 per cent due to high level of seller competition limiting price growth, it said.
UK house prices have experienced their sharpest July decline in over two decades (Getty/iStock)
Despite this, the property website maintains its prediction of 1.15 million property transactions for the current year.
The data indicates that London, particularly inner London, has been a key driver of lower asking prices. Price tags across the capital have seen a 1.5 per cent month-on-month fall, escalating to an average 2.1 per cent decline in inner London.
April's increase in stamp duty has had a particular impact in London where property prices are higher, the website added.
By contrast, the north east of England has seen a 1.2 per cent increase in prices month-on-month, continuing a trend of less expensive areas seeing faster price growth.
With mortgage rates falling and two more Bank of England base rate cuts still expected in 2025, the overall outlook for the second half of the year remains positive, the Rightmove report adds.
Many lenders have recently made changes to their criteria, allowing some borrowers to potentially take out bigger loans.r
Rightmove's map shows average asking price changes across Britain (Rightmove)
Rightmove's mortgage tracker indicates that the average two-year fixed mortgage rate is 4.53 per cent, compared with 5.34 per cent a year earlier.
Colleen Babcock, a property expert at Rightmove, said: 'We're seeing an interesting dynamic between pricing and activity levels right now.
'The healthy and improving level of property sales being agreed shows us that there are motivated buyers out there who are willing to finalise a deal for the right property.
'The decade-high level of buyer choice means that discerning buyers can quickly spot when a home looks overpriced compared to the many others that may be available in their area.
Ms Babcock added: 'Crucially, buyer affordability is heading in the right direction, and another two (Bank of England base rate) cuts before 2026 would be a big boost to this.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 minutes ago
- Yahoo
Ontario Real Estate Association Appoints Luigi Favaro as New Chief Executive Officer
TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- The Ontario Real Estate Association (OREA) Board of Directors is pleased to announce the appointment of Luigi Favaro as its new Chief Executive Officer (CEO), effective September 2, 2025. In this role, Favaro will lead the organization in its continued efforts to advocate on behalf of nearly 100,000 REALTOR® Members and support them in their pursuit of building stronger communities across the province. Favaro brings nearly 20 years of experience in the real estate industry, with a proven track record in leadership, strategic development, and organizational growth. He currently serves as Vice President of Partnerships at OREA and, over the years, has been responsible for expanding the organization's strategic partnerships, overseeing the development of Member Board support programs, and launching key association initiatives that enhanced Member satisfaction. 'We are thrilled to have Luigi lead the Association and drive our strategic direction during such a pivotal time,' said OREA President Cathy Polan. 'With his extensive experience in both leadership and real estate, we are confident he will provide the vision and direction necessary to continue elevating our Association and strengthening the profession. We thank OREA Interim CEO Sonia Richards for her steadfast leadership over the last year and her work in ensuring our Members continued to receive the support they deserve.' Favaro is enthusiastic about the future of OREA with him at the helm, saying 'I am honoured to continue working with our Members, staff, and stakeholders to further our mission of supporting Ontario REALTORS® in helping people find a great place to call home, work and thrive. Together, we will continue to address the challenges and opportunities facing our profession and ensure that our Members are equipped for success.' For more information, please contact: Jean-Adrien DelicanoSenior Manager, Media Relations, OREAJeanAdrienD@ A photo accompanying this announcement is available at in to access your portfolio
Yahoo
4 minutes ago
- Yahoo
Plan for new Glasgow hall rejected after residents all said the same thing
A plan to turn a Glasgow home into a meeting hall has been rejected after residents shared one complaint. Glasgow City Council planning officials declined Muhammad Akram's proposal to transform the residential property at 71 Albert Road in Crosshill. The committee cited several policies which the bid goes against, including that the new venue would likely "raise unacceptable noise and activity issues, which would be detrimental to the neighbours within the locale". Another reason was that the hall "fails to provide car parking, public and staff cycle parking and end trip facilities for staff". The decision came after 15 objections were submitted against the proposal, quoting difficulties with parking. READ NEXT: This retailer has plan for historic Queen Street building One resident said: "A change of use will inevitably increase car traffic and parking, which is already unsustainable and impacts the safety of other road users, including cyclists and children." Another wrote: "I am concerned about the impact on traffic and parking caused by the proposed change in purpose. "This will bring additional users looking for parking spaces. The existing facility next door already causes problems (e.g. mothers double-parking when collecting children from classes). "A residential street cannot just 'absorb' this increased need for parking spaces." A third noted: "I must object to this application in the strongest possible terms, on the grounds of the increased traffic and almost guaranteed issues with illegal parking that this proposed development will bring to Albert Road." A fourth added: "The local infrastructure is not designed to support non-residential use at this location. Increased traffic, noise and demand on limited services would follow, negatively affecting residents and further diminishing the area's residential nature. "We have already seen the serious impact at the neighbouring property, which is in domestic use but frequently functions as a venue."
Yahoo
33 minutes ago
- Yahoo
UK-India $4.8bn FTA poised to benefit medtech and pharma
The UK and India's newly signed £4.8bn ($6.45bn) free trade agreement (FTA) is expected to give rise to new opportunities for Indian medical device and pharmaceutical manufacturers. Signed on 24 July, India's medical device and pharmaceutical industries expect the agreement to reduce the regulatory burden around Indian exports to the UK, which include contact lenses, diagnostic reagents, and surgical instruments. While the UK already has zero-duty access for Indian medical devices, the agreement means India will gradually phase down import duties on UK medical devices from 7.5%–15% to 3%, rendering British medical device exports more affordable to the Indian market. According to the Medical Technology Association of India (MTAI), the agreement will improve access to advanced medical technologies and enable joint ventures, skilling, and long-term ecosystem resilience. India is a strategic site for orthopaedics maker Smith+Nephew's manufacturing activities. Smith+Nephew CEO Deepak Nath commented: 'The FTA offers the potential to build trading links in the healthcare sector. 'We hope that the FTA will enable Smith+Nephew's innovative medical technologies to support more healthcare professionals.' While the FTA has been met with optimism by the medical device industry at large, some observers are concerned that Chinese-origin products could be routed through the UK to exploit the zero-tariff provisions under an India-UK FTA. A source from the India commerce ministry's Export Promotion Council of Medical Devices (EPCMD) told Mint: 'To prevent this, it is critical to enforce strict rules of origin, including a minimum of 55% UK content, excluding labour, packing, and shipping costs." Pharma impact Under the FTA, the Indian Pharmaceutical Alliance (IPA) secretary general Sudarshan Jain said: 'The pharma sector will have opportunities to supply affordable and quality assured medicine contributing to better patient care in the UK.' The FTA includes a clause for zero import duty to the UK on finished formulations, APIs, and bulk drugs that is expected to benefit generic drug makers in India. According to Namit Joshi, the chairman of government body Pharmaceuticals Export Promotion Council of India (Phaemexcil), the FTA agreement sets the stage for further collaborations between the countries in bulk drug imports, CDMO, and joint research initiatives. In 2024, UK imports of medicinal and pharmaceutical products from India totalled around £667.4m ($897.1m). An Indian commerce ministry official told Indian news agency PTI: 'Given the UK's shift away from reliance on Chinese imports post-Brexit and Covid-19, Indian manufacturers are poised to emerge as a favoured, cost-effective alternative.' "UK-India $4.8bn FTA poised to benefit medtech and pharma" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data